SCHEMBL213871

SCHEMBL213871

C[CH]c1cccnc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9368994 0.81
SCHEMBL302926 0.81
SCHEMBL154139 0.81
SCHEMBL29691639 0.79 CYP11B1 (0.86)
SCHEMBL29691623 0.79 CYP11B1 (0.86)
SCHEMBL8911420 0.79 ALDH1A1 (0.62)
SCHEMBL73921 0.77
SCHEMBL29691464 0.77 CYP11B1 (0.82)
SCHEMBL29691514 0.77 CYP11B1 (0.82)
SCHEMBL29691532 0.77 CYP11B1 (0.82)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 974 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114853729-B Quinazoline-2-ketone compound and preparation method and application thereof 汕头大学医学院 2024-03-29 CN claimed
CN-115785091-A Method for catalytically synthesizing tetrahydro-beta-carboline compound by utilizing PNP type pincerlike manganese catalyst 邵秀兰 2023-03-14 CN claimed
CN-114853729-A Quinazoline-2-ketone compound and preparation method and application thereof 汕头大学医学院 2022-08-05 CN claimed
CN-110511214-B Diamine substituted aromatic heterocyclic compound and preparation method and application thereof 浙江工业大学 2021-07-27 CN claimed
EP-3226868-A1 NOVEL QUINAZOLINES AS BIOGENIC AMINE TRANSPORT MODULATORS Ananthan, Subramaniam (US) 2017-10-11 EP claimed
EP-3226867-A1 HETEROCYCLIC COMPOUNDS AS BIOGENIC AMINE TRANSPORT MODULATORS Ananthan, Subramaniam (US) 2017-10-11 EP claimed
US-9745305-B2 Modulators of methyl modifying enzymes, compositions and uses thereof CONSTELLATION PHARMACEUTICALS, INC. (US) 2017-08-29 US claimed
CN-107080700-A Include the colouring compositions of fatty material, Pyrazolopyridine oxidation base and colour coupler 莱雅公司 2017-08-22 CN claimed
EP-2970305-B1 MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF CONSTELLATION PHARMACEUTICALS INC (US) 2017-02-22 EP claimed
EP-2352723-B1 PESTICIDAL N-ARYL- OR N-HETEROARYL PYRAZOLE CARBOXAMIDE COMPOUNDS BAYER IP GMBH (DE) 2016-11-23 EP claimed
WO-1996029329-A1 CYCLIC UREA HIV PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-09-26 WO claimed
US-5559140-A VIRICIDES MERRELL PHARMACEUTICALS INC. (US) 1996-09-24 US claimed
EP-0565631-B1 ANTI-VIRAL COMPOUNDS MERRELL PHARMA INC (US) 1996-09-18 EP claimed
EP-0673254-A1 6-POSITION MODIFIED DECAPEPTIDE LHRH ANTAGONISTS ABBOTT LABORATORIES (US) 1995-09-27 EP claimed
WO-1995009859-A1 BOROPEPTIDE INHIBITORS OF THROMBIN WHICH CONTAIN A SUBSTITUTED PYRROLIDINE RING THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-04-13 WO claimed
WO-1994019008-A1 COMBINATIONS OF RETROVIRAL INHIBITORS MERRELL DOW PHARMACEUTICALS INC. (US) 1994-09-01 WO claimed
WO-1994013313-A1 6-POSITION MODIFIED DECAPEPTIDE LHRH ANTAGONISTS ABBOTT LABORATORIES (US) 1994-06-23 WO claimed
EP-0565631-A1 ANTI-VIRAL COMPOUNDS. MERRELL DOW PHARMA (US) 1993-10-20 EP claimed
WO-1992012123-A1 ANTI-VIRAL COMPOUNDS MERRELL DOW PHARMACEUTICALS INC. (US) 1992-07-23 WO claimed
EP-0289639-A1 Use of trigonellin to revive, to stimulate and to enhance hair growth Mai, Jutta (DE) 1988-11-09 EP claimed